Matt Halpert 1 source tracked

Cancer immunologist and co-founder of Diakonos Oncology, developing dendritic cell–based immunotherapies for cancer.

About Matt Halpert →

Matt Halpert is a cancer immunologist known for his work on dendritic cell–based cancer immunotherapy. He earned his Ph.D. in Microbiology and Immunology from the University of Alabama at Birmingham and spent roughly a decade as a cancer immunology researcher at Baylor College of Medicine, where his work included findings on CTLA-4 production by dendritic cells. He is a co-founder of Diakonos Oncology and is associated with the Immunocine Cancer Center, where he has helped develop dendritic cell therapies that have entered FDA clinical trials, including a Fast Track trial in glioblastoma.

6
Recommendations
6
Endorses
0
Avoids
0
Neutral
1
Protocols
+ 4 more topics